Interferon regulatory factor pathway (IRF pathway)

The Interferon Regulatory Factor (IRF) pathway comprises a family of nine mammalian transcription factors (IRF1 through IRF9) that act as essential mediators of the host immune response. These proteins are activated downstream of various pattern recognition receptors (PRRs)—such as Toll-like receptors (TLRs), RIG-I, and STING—to orchestrate the induction of type I interferons (IFN-α/β) and numerous interferon-stimulated genes (ISGs). In addition to their primary roles in antiviral defense and innate immunity, IRF members regulate cellular processes including hematopoiesis, cell cycle progression, and apoptosis. Dysregulation of the IRF pathway is a hallmark of many pathological states; over-activation is frequently associated with autoimmune disorders like systemic lupus erythematosus, while loss-of-function or aberrant expression is implicated in oncogenesis and increased susceptibility to severe viral infections. Therapeutic efforts include the development of IRF4 antisense oligonucleotides for hematologic malignancies and the use of immunomodulatory drugs like lenalidomide, as well as the exploration of small-molecule inhibitors and agonists to modulate specific IRF activities in inflammatory and infectious disease contexts.

Other names

IRF signalingInterferon regulatory factor familyIRF cascadeInterferon-responsive transcription factor pathway

Modulation of the pathway includes targeted mRNA degradation via antisense oligonucleotides, E3 ligase-mediated degradation of transcription factor proteins, and activation of upstream pattern recognition receptors (e.g., STING and TLRs) to induce nuclear translocation and DNA binding of IRF proteins.